Participation Form

We will notify the Study Coordinator for "PILOT STUDY TO EVALUATE THE ANTI-TUMOR EFFECT OF DURVALUMAB IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN), HUMAN PAPILLOMA VIRUS (HPV) POSITIVE VERSUS NEGATIVE, WHEN TREATED BEFORE SURGERY," on your behalf, that you would like to participate in this study.

Please fill out the form below and click "Submit" to send a notification request.

or Cancel

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.